The Usefulness of a Novel Screening Kit for Colorectal Cancer Using the Immunochromatographic Fecal Tumor M2 Pyruvate Kinase Test
Open Access
- 23 September 2015
- journal article
- research article
- Published by The Editorial Office of Gut and Liver in Gut and Liver
- Vol. 9 (5) , 641-648
Abstract
Yong Cheol Kim, Jeong Ho Kim, Dae Young Cheung, Tae Ho Kim, Eun Jung Jun, Jung-Whan Oh, Chang Whan Kim, Woo Chul Chung, Byung-Wook Kim, Sung Soo Kim, Jin Il Kim, Soo-Heon Park, and Jae Kwang Kim. Gut and Liver 2015;9:641-8. https://doi.org/10.5009/gnl13457Keywords
This publication has 29 references indexed in Scilit:
- Cancer Statistics in Korea: Incidence, Mortality, Survival and Prevalence in 2010Cancer Research and Treatment, 2013
- Faecal pyruvate kinase isoenzyme type M2 for colorectal cancer screening: A meta-analysisWorld Journal of Gastroenterology, 2012
- Comparison of immunochemical and guaiac‐based fecal occult blood test in screening and surveillance for advanced colorectal neoplasms: A meta‐analysisJournal of Digestive Diseases, 2010
- The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growthNature, 2008
- Pyruvate kinase M2 is a phosphotyrosine-binding proteinNature, 2008
- Colorectal cancer screening in average risk individualsCancer Causes & Control, 2005
- Sensitivity and Specificity of a Stool DNA Multitarget Assay Panel for the Detection of Advanced Colorectal NeoplasiaClinical Colorectal Cancer, 2003
- Tumor M2-pyruvate kinase: a promising tumor marker in the diagnosis of gastro-intestinal cancer.2001
- Tumor M2-PK and glutaminolytic enzymes in the metabolic shift of tumor cells.2001
- Colorectal cancer screening by detection of altered human DNA in stool: Feasibility of a multitarget assay panelGastroenterology, 2000